Drug everolimus does not improve overall survival in patients with advanced liver cancer
Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study in the July 2 issue of JAMA.
Jul 1, 2014